Drugs / ONO-4474
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02454387 | May 2015 → Apr 2016 | osteoarthritis | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02997696 | Jan 2017 → Jan 2018 | osteoarthritis, knee | Ono Pharmaceutical Co., Ltd. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONO-4474 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02997696 ↗ |
| Route | Oral | “following 4 weeks of oral administration of ONO-4474” NCT02997696 ↗ |